Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proxy Advisory Group is an independent professional services firm specializing in proxy solicitation, shareholder identification, and corporate governance consulting. The firm provides strategic advice to publicly traded companies, including those in the biotechnology and pharmaceutical sectors, to manage shareholder meetings and navigate complex corporate actions such as mergers and acquisitions. Proxy Advisory Group assists management teams and boards of directors in understanding institutional investor voting policies and executing effective communication campaigns to secure shareholder support. Their expertise is particularly relevant for life science companies facing activist investors or undergoing significant structural changes. By providing detailed shareholder analysis and tactical outreach, the firm helps ensure that corporate objectives are aligned with investor expectations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proxy Advisory Group.